OmniAb Investor Conference Presentation Deck

Diverse Drug Formats and Modalities PRECLINICAL AND CLINICAL OMNIAB MOLECULES IgG Fab-Heavy chain (Knob-in-hole) FORMATS Duobody Ⓡ (IgG4 exchange) IgG-scFv ADAPTIR™M scFv-Fc-scFv Antibody-Drug Conjugate Bispecific (incl. T cell engager) 37% MODALITIES ADC 6% Variety in the formats and modalities used by partners demonstrating the flexibility of our platform Monoclonal IgG 57% 16 OmniAb

View entire presentation